Gilead $GILD said remdesivir, an experimental COVID-19 drug, may reduce deaths, though it noted the findings need to be confirmed. “This is very encouraging but needs to be confirmed in a prospective trial,” said the former commissioner of the FDA.
Shares of Gilead Sciences Inc. gained 2.0% on Friday after the drugmaker shared potentially promising data about remdesivir that indicates the experimental COVID-19 drug may reduce deaths, though it noted the findings need to be confirmed.
Gilead agreed, saying the new findings require “confirmation in prospective clinical trials” although the company did not say whether it plans to conduct those studies.The source for the analysis, however, is unorthodox. It’s not from a randomized, placebo-controlled clinical trial, which has long been considered the gold standard for medical research in the U.S., and it compares clinical trial data to non-clinical trial data.
A pair of closely watched double-blind, randomized, controlled trials in China were halted early due to enrollment issues but a study published in The Lancet about the multi-site trial in China did not indicate a mortality benefit.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Gilead says remdesivir coronavirus treatment reduces risk of death
続きを読む »
A new Gilead analysis indicates remdesivir can reduce death but company says finding 'requires confirmation'Shares of Gilead Sciences Inc. undefined gained 2.0% in premarket trading on Friday after the drugmaker disclosed findings from a new analysis of previously...
続きを読む »
Stocks Cut Losses After Gilead Says Remdesivir Coronavirus Treatment Reduces Risk Of DeathThe market opened flat as investors weigh a recent spike in new cases with positive vaccine news.
続きを読む »
Gilead says remdesivir coronavirus treatment reduces risk of death in severely sick patientsThe findings show that 7.6% of patients treated with remdesivir died compared with 12.5% of patients in the analysis who did not receive remdesivir treatment.
続きを読む »
Stocks Cut Losses After Gilead Says Remdesivir Coronavirus Treatment Reduces Risk Of DeathStocks cut losses today after Gilead said that the remdesivir coronavirus treatment reduces the risk of death by skleb1234
続きを読む »
Gilead analysis shows remdesivir reduced coronavirus death risk, more studies neededGilead Sciences Inc said on Friday an analysis showed its antiviral remdesivir helped reduce the risk of death in severely ill COVID-19 patients, but cautioned that rigorous clinical trials were needed to confirm the benefit.
続きを読む »